Virtual cancer clinic Perci Health raises £3m after doubling funding target
Perci Health co-founder and chief executive Kelly McCabe said: “Our mission to close the cancer care gap is powered by an outstanding team who are deeply committed to transforming the cancer care experience.
“This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”
The round included £295,000 from Macmillan Cancer Support, with new backing from Guinness Ventures and Conduit Fund. Existing investors Octopus Ventures and 35 of the UK’s leading oncologists and cancer surgeons also participated.
Perci Health’s platform aims to address gaps in cancer services by offering support for prevention, early detection, treatment navigation, symptom management and survivorship care – the long-term support people need after active treatment ends.
Co-founder and chief customer officer Morgan Fitzsimons said: “We know that cancer doesn’t stop when treatment ends. In fact, that’s often when people need the most support.
“Perci Health’s AI-driven platform ensures truly personalised care, enabling people to access the right support at the right time.”
The company’s model is designed to help working-age people with cancer regain independence and financial stability, while also contributing to wider efforts to reduce economic inactivity linked to ill health.
With a team of more than 85 specialists, the funding will support expansion of partnerships with employers and insurers.
Chantal Cox, investor at Octopus Ventures, said: “We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model.
“This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”
Perci Health is one of the few UK scale-ups with an all-female founding team.
All directors are women, along with 80 per cent of the leadership team and 60 per cent of the executive board – notable in a sector where less than 2 per cent of venture capital typically goes to female-led teams.
